Newsroom

Sorted by: Latest

-

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Padcev® (enfortumab vedotin-ejfv), as neoadjuvant treatment and then continued after radical cystectomy as adjuvant treatment for adults with resectable muscle-invasiv...
-

Elowen Capital Structures $101 Million Capitalization for ECA's Texas Expansion

RALEIGH, N.C.--(BUSINESS WIRE)--Elowen Capital has structured and sourced $101 million in total capitalization for ECA's acquisition of a 20-property, 1,576-unit multifamily portfolio spanning 13 cities across Texas. The capitalization combines $94.2 million in senior and stretch senior bridge debt across two independent lenders with $6.7 million in limited partner equity. The debt consists of interest-only bridge loans provided by RRA Capital and The Bancorp, structured to support both the acq...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 17.09.2026 FKU IE00B8X9NZ57  181,700.00 GBP   8,211,082.08   45.190  ...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Pentair Appoints Louis Pinkham to Board of Directors

LONDON--(BUSINESS WIRE)--Pentair plc (NYSE: PNR), a leader in helping the world sustainably move, improve and enjoy water, life’s most essential resource, today announced that Louis Pinkham has been appointed to its board of directors, effective September 17, 2026. Mr. Pinkham will serve on the Company’s Audit and Finance Committee.With decades of leadership experience in the industrial manufacturing, electrical equipment and power management industries, Mr. Pinkham most recently served as Chief...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 17.09.2026 FKUD IE00BD9N0445  121,463.00 GBP   3,798,992.45   31.277  ...
-

GMKtec Unveils EVO-X5 Pro at IFA 2026 with AMD Ryzen(TM) AI Max Processors, Introducing the World's First Desktop AI Supercomputer Capable of Running a 300B-Parameter LLM Fully Offline

BERLIN--(BUSINESS WIRE)--GMKtec officially unveiled the EVO-X5 Pro, its flagship desktop AI supercomputer, during its global launch event at IFA 2026, marking a major milestone in the evolution of local AI computing. Powered by AMD's latest Ryzen™ AI Max+ PRO 495 processor, the EVO-X5 Pro is the world's first desktop system capable of running a 300-billion-parameter large language model entirely offline, bringing enterprise-grade AI performance and data privacy to the desktop. EVO-X5 Pro launch...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 17.09.2026 FPX. IE00BYTH6238  250,002.00 USD  16,546,437.98   66.185  ...